Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q1 2022 call → NOWe need to determine if management explains the company's business direction by narrating what its counterparties are doing and scaling. The question asks if a substantial part of management's forward account consists of reporting on the growth, expansion, ramp, adoption, or program build-out of specific customers, partners, etc., that the company already supplies, such that the company's own coming volume is a consequence of those parties' trajectories. Let's analyze the transcript. Management (Josef Matosevic and Tricia Fulton) discusses results, guidance, supply chain, acquisitions, etc. They mention strong demand, market share gains, and their own strategies. They talk about their manufacturing strategy, new products, and operational excellence. They mention specific end markets like health and wellness, recreational markets, and China construction. However, they do not narrate specific counterparties' own expansion plans, ramps, or build-outs. They talk about demand from customers generally, but not about specific customers' trajectories. They mention their own capacity additions and supply chain management. They do not describe a particular customer or partner scaling up and driving their business. The acquisition of PME is discussed, but that's about a company they are acquiring, not a counterparty they supply. They mention their own lead times and market share gains. There is no narrative about a specific customer's program or build-out. They talk about broad market conditions and their own actions. Therefore, the answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.